Neurocrine Biosciences Stock Price History

NBIX Stock  USD 145.66  2.93  2.05%   
Below is the normalized historical share price chart for Neurocrine Biosciences extending back to May 23, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Neurocrine Biosciences stands at 145.66, as last reported on the 19th of September, with the highest price reaching 146.03 and the lowest price hitting 143.34 during the day.
IPO Date
23rd of May 1996
200 Day MA
125.5829
50 Day MA
134.6908
Beta
0.283
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Neurocrine Stock, it is important to understand the factors that can impact its price. Neurocrine Biosciences appears to be very steady, given 3 months investment horizon. Neurocrine Biosciences has Sharpe Ratio of 0.15, which conveys that the firm had a 0.15 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Neurocrine Biosciences, which you can use to evaluate the volatility of the firm. Please exercise Neurocrine Biosciences' Downside Deviation of 1.87, mean deviation of 1.19, and Risk Adjusted Performance of 0.1015 to check out if our risk estimates are consistent with your expectations.
At this time, Neurocrine Biosciences' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 3.9 B in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 63.6 M in 2025. . At this time, Neurocrine Biosciences' Price Earnings Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 6.06 in 2025, whereas Price To Sales Ratio is likely to drop 5.53 in 2025. Neurocrine Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1477

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsNBIX
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.7
  actual daily
15
85% of assets are more volatile

Expected Return

 0.25
  actual daily
5
95% of assets have higher returns

Risk-Adjusted Return

 0.15
  actual daily
11
89% of assets perform better
Based on monthly moving average Neurocrine Biosciences is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neurocrine Biosciences by adding it to a well-diversified portfolio.
Price Book
5.1868
Enterprise Value Ebitda
24.1173
Price Sales
5.6401
Shares Float
98 M
Wall Street Target Price
168.2515

Neurocrine Biosciences Stock Price History Chart

There are several ways to analyze Neurocrine Stock price data. The simplest method is using a basic Neurocrine candlestick price chart, which shows Neurocrine Biosciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 18, 2025145.66
Lowest PriceAugust 11, 2025123.98

Neurocrine Biosciences September 19, 2025 Stock Price Synopsis

Various analyses of Neurocrine Biosciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Neurocrine Stock. It can be used to describe the percentage change in the price of Neurocrine Biosciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Neurocrine Stock.
Neurocrine Biosciences Accumulation Distribution 14,532 
Neurocrine Biosciences Price Daily Balance Of Power 1.09 
Neurocrine Biosciences Price Action Indicator 2.44 
Neurocrine Biosciences Price Rate Of Daily Change 1.02 

Neurocrine Biosciences September 19, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Neurocrine Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Neurocrine Biosciences intraday prices and daily technical indicators to check the level of noise trading in Neurocrine Stock and then apply it to test your longer-term investment strategies against Neurocrine.

Neurocrine Stock Price History Data

The price series of Neurocrine Biosciences for the period between Sat, Jun 21, 2025 and Fri, Sep 19, 2025 has a statistical range of 21.68 with a coefficient of variation of 4.36. The daily prices for the period are spread out with arithmetic mean of 133.13. The median price for the last 90 days is 132.9. The company issued dividends to stockholders on 1995-12-29.
OpenHighLowCloseVolume
09/18/2025
 143.86  146.03  143.34  145.66  788,875 
09/17/2025
 141.67  143.39  141.18  142.73  610,921 
09/16/2025
 140.44  141.02  139.25  140.90  780,536 
09/15/2025 141.73  141.81  139.38  140.44  633,764 
09/12/2025
 142.44  144.04  141.73  141.87  485,690 
09/11/2025 141.50  143.82  141.50  143.60  674,646 
09/10/2025
 144.35  145.16  140.56  141.25  767,378 
09/09/2025
 143.50  144.21  141.78  144.17  569,709 
09/08/2025 143.02  144.53  142.09  143.80  973,837 
09/05/2025 140.76  145.79  136.50  144.10  1,227,867 
09/04/2025 136.32  140.50  135.66  140.40  772,402 
09/03/2025 141.64  142.54  135.61  136.11  1,500,052 
09/02/2025 139.08  142.91  138.57  141.92  786,333 
08/29/2025
 139.00  140.03  138.07  139.60  503,700 
08/28/2025 138.10  139.07  137.00  138.94  449,618 
08/27/2025
 136.94  139.03  136.94  138.13  740,926 
08/26/2025 133.94  137.14  133.62  136.84  1,105,580 
08/25/2025
 134.95  135.71  133.69  133.99  530,293 
08/22/2025
 135.97  137.03  134.31  135.43  547,980 
08/21/2025
 133.26  135.63  132.41  135.28  553,371 
08/20/2025
 133.28  133.71  131.91  133.23  518,762 
08/19/2025
 133.21  134.78  132.76  132.81  674,793 
08/18/2025
 132.77  133.54  132.37  133.14  585,254 
08/15/2025
 131.57  133.25  131.20  132.90  558,515 
08/14/2025
 130.66  132.11  130.26  131.31  782,803 
08/13/2025
 129.99  131.79  129.85  131.62  1,056,635 
08/12/2025
 124.39  129.04  124.36  128.89  994,361 
08/11/2025
 124.54  125.91  123.69  123.98  923,003 
08/08/2025 125.50  126.44  123.67  125.01  1,048,379 
08/07/2025 129.35  129.35  124.79  125.60  1,225,622 
08/06/2025
 127.79  128.53  126.45  128.43  823,220 
08/05/2025
 127.88  128.74  126.60  128.39  879,999 
08/04/2025
 128.91  128.91  125.37  128.04  1,529,315 
08/01/2025
 126.40  129.09  124.54  128.91  1,395,006 
07/31/2025
 137.10  137.44  127.25  128.23  2,914,169 
07/30/2025 135.53  137.12  133.63  136.76  1,443,601 
07/29/2025
 134.27  135.38  133.09  134.19  1,038,479 
07/28/2025
 132.49  134.44  132.01  133.71  757,826 
07/25/2025
 133.12  133.12  130.75  132.14  1,255,339 
07/24/2025
 133.47  135.00  131.43  131.64  885,761 
07/23/2025
 133.90  134.32  132.10  133.66  773,184 
07/22/2025
 132.52  133.32  132.22  132.75  575,505 
07/21/2025 133.16  133.80  131.51  131.83  470,131 
07/18/2025
 134.94  134.94  131.12  132.02  757,716 
07/17/2025
 132.71  135.70  131.88  134.11  674,476 
07/16/2025
 131.24  134.25  131.07  133.48  905,536 
07/15/2025
 135.49  136.25  131.13  131.24  629,496 
07/14/2025
 132.34  135.45  131.75  135.13  613,126 
07/11/2025
 134.00  135.00  132.10  133.46  724,779 
07/10/2025
 134.63  135.94  132.74  134.92  1,051,177 
07/09/2025
 130.11  133.69  128.94  133.51  1,261,276 
07/08/2025
 127.76  129.78  127.73  128.74  753,937 
07/07/2025
 128.59  129.07  127.03  127.88  537,971 
07/03/2025
 129.94  131.00  128.47  129.11  387,387 
07/02/2025
 127.55  130.42  127.52  129.40  1,189,085 
07/01/2025
 126.20  129.27  126.15  128.00  924,723 
06/30/2025
 125.42  127.36  125.42  125.69  679,416 
06/27/2025
 126.71  127.26  125.02  125.42  1,262,138 
06/26/2025
 128.17  128.66  126.20  126.71  476,363 
06/25/2025
 127.73  128.61  126.61  127.78  576,123 
06/24/2025
 126.39  128.50  123.04  128.18  819,936 

About Neurocrine Biosciences Stock history

Neurocrine Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neurocrine is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neurocrine Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neurocrine Biosciences stock prices may prove useful in developing a viable investing in Neurocrine Biosciences
Last ReportedProjected for Next Year
Common Stock Shares Outstanding103.7 M63.6 M
Net Income Applicable To Common Shares177.7 M186.6 M

Neurocrine Biosciences Quarterly Net Working Capital

1.2 Billion

Neurocrine Biosciences Stock Technical Analysis

Neurocrine Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Neurocrine Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Neurocrine Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Options Analysis Now

   

Options Analysis

Analyze and evaluate options and option chains as a potential hedge for your portfolios
All  Next Launch Module

Neurocrine Biosciences Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Neurocrine Biosciences' price direction in advance. Along with the technical and fundamental analysis of Neurocrine Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neurocrine to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Neurocrine Stock Analysis

When running Neurocrine Biosciences' price analysis, check to measure Neurocrine Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurocrine Biosciences is operating at the current time. Most of Neurocrine Biosciences' value examination focuses on studying past and present price action to predict the probability of Neurocrine Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurocrine Biosciences' price. Additionally, you may evaluate how the addition of Neurocrine Biosciences to your portfolios can decrease your overall portfolio volatility.